For comments, suggestions
Created with Raphaël 2.1.0 28.04.2016 Filing date 07.12.2017 Validation fee payment 30.04.2018 (A1) Patent application published 10.04.2020 AGEPI application filing date 31.07.2020 (T2) Translation of the validated European patent 25.05.2025 28.04.2026 Valid until 29.04.2027 Renewal fee to be paid until 28.04.2036 Patent will expire on

Patent in force


(210)Number of the EPO application16721605
(220)Filing date of the EPO application2016.04.28
(80)EPO patent specification publication (B)EPB nr. 07/2020, 2020.02.12
(110)EPO patent number3292141
(11)Number of the documentMD 3292141 T2
(21)Number of the applicatione 2018 0255
(71)Name(s) of applicant(s), code of the countryELI LILLY AND COMPANY, US;
(72)Name(s) of inventor(s), code of the countryBALDWIN David Bruce, US;
BEALS John Michael, US;
DAY Jonathan Wesley, US;
DICKINSON Craig Duane, US;
KORYTKO Andrew Ihor, US;
LAZAR Gregory Alan, US;
(73)Name(s) of owner(s), code of the countryELI LILLY AND COMPANY, US;
(54)Title of the inventionFusion proteins
(13)Kind-of-document code T2
(51)International Patent Classification C07K 14/62 (2006.01.01); A61K 38/28 (2006.01.01); C12N 15/62 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2018.04.30
(49)Date of publication of the translation of the validated European patent specification2020.07.31
(30)Priority201562158079 P, 2015.05.07, US
(74)Patent attorney(Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova
(86)International applicationPCT/US2016/029807, 2016.04.28
(87)International publicationWO 2016/178905, 2016.11.10
Up
/Inventions/details/3292141